[{"id":"dbb381f3-556a-40e9-85b7-bab607e825f2","acronym":"aMILs","url":"https://clinicaltrials.gov/study/NCT01045460","created_at":"2023-08-03T04:08:22.548Z","updated_at":"2024-07-02T16:36:32.145Z","phase":"Phase 2","brief_title":"Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma","source_id_and_acronym":"NCT01045460 - aMILs","lead_sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","biomarkers":" BGLAP","pipe":"","alterations":" ","tags":["BGLAP"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • melphalan • Neupogen (filgrastim)"],"overall_status":"Completed","enrollment":" Enrollment 36","initiation":"Initiation: 01/15/2010","start_date":" 01/15/2010","primary_txt":" Primary completion: 12/01/2014","primary_completion_date":" 12/01/2014","study_txt":" Completion: 06/01/2020","study_completion_date":" 06/01/2020","last_update_posted":"2021-04-09"}]